Cargando…

Dyslipidemia Associated with Chronic Kidney Disease

Cardiovascular disease is a major cause of morbidity and mortality in patients with impaired renal function. Dyslipidemia has been established as a well-known traditional risk factor for cardiovascular disease (CVD) in the general population and it is well known that patients with chronic kidney dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsimihodimos, Vasilis, Mitrogianni, Zoi, Elisaf, Moses
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106357/ https://www.ncbi.nlm.nih.gov/pubmed/21643500 http://dx.doi.org/10.2174/1874192401105010041

Ejemplares similares

Hypercalcemia and acute renal failure associated with calcium carbonate consumption in a patient with hypoparathyroidism
por: Mitrogianni, Zoi, et al.
Publicado: (2014)

Editorial: Secondary Dyslipidemias
por: Elisaf, Moses, et al.
Publicado: (2011)

No effect of fenugreek, bergamot and olive leaf extract on glucose homeostasis in patients with prediabetes: a randomized double-blind placebo-controlled study
por: Florentin, Matilda, et al.
Publicado: (2019)

Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes
por: Kostara, Christina E., et al.
Publicado: (2020)

Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS Adipocytes
por: Derdemezis, Christos S., et al.
Publicado: (2011)

Nicotinic acid/laropiprant reduces platelet count but increases mean platelet volume in patients with primary dyslipidemia
por: Kei, Anastazia, et al.
Publicado: (2014)

LDL cholesterol estimation in patients with the metabolic syndrome
por: Gazi, Irene, et al.
Publicado: (2006)

Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
por: Filippatos, Theodosios D., et al.
Publicado: (2017)

Association of Dyslipidemia with Renal Outcomes in Chronic Kidney Disease
por: Chen, Szu-Chia, et al.
Publicado: (2013)

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
por: Moutzouri, Elisavet, et al.
Publicado: (2010)

Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
por: Kochan, Zdzislaw, et al.
Publicado: (2021)

PCSK9 and carbohydrate metabolism: A double-edged sword
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

The Impact of Dietary Glycemic Index and Glycemic Load on Postprandial Lipid Kinetics, Dyslipidemia and Cardiovascular Risk
por: Lambadiari, Vaia, et al.
Publicado: (2020)

Thyroid dysfunction and dyslipidemia in chronic kidney disease patients
por: Khatiwada, Saroj, et al.
Publicado: (2015)

Dyslipidemia in patients with chronic kidney disease: etiology and management
por: Mikolasevic, Ivana, et al.
Publicado: (2017)

Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview
por: Suh, Sang Heon, et al.
Publicado: (2023)

The Development of Dyslipidemia in Chronic Kidney Disease and Associated Cardiovascular Damage, and the Protective Effects of Curcuminoids
por: Ceja-Galicia, Zeltzin Alejandra, et al.
Publicado: (2023)

Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
por: Ohsawa, Masato, et al.
Publicado: (2015)

Attainment of cholesterol target values in Greece: results from the Dyslipidemia International Study II
por: Liberopoulos, Evangelos, et al.
Publicado: (2018)

The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study
por: Liang, Xudong, et al.
Publicado: (2020)

The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology
por: Dimou, Aikaterini, et al.
Publicado: (2022)

Effects of low-dose niacin on dyslipidemia and serum phosphorus in patients with chronic kidney disease
por: Jin Kang, Hyo, et al.
Publicado: (2013)

Effect of Clinical and Laboratory Parameters on HDL Particle Composition
por: Kostara, Christina E., et al.
Publicado: (2023)

Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study
por: YAMADA, YOSHIJI, et al.
Publicado: (2015)

Lipidomics in non-alcoholic fatty liver disease
por: Kartsoli, Sofia, et al.
Publicado: (2020)

Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital
por: Sangsawang, Tamon, et al.
Publicado: (2015)

Effect of the first and second COVID-19 associated lockdown on the metabolic control of patients with type 2 diabetes in Greece
por: Papachristoforou, Eleftheria, et al.
Publicado: (2023)

The Pattern of Dyslipidemia in Chronic Liver Disease Patients
por: Farooque, Umar, et al.
Publicado: (2021)

Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism
por: Czumaj, Aleksandra, et al.
Publicado: (2019)

Metformin Suppresses Thioacetamide-Induced Chronic Kidney Disease in Association with the Upregulation of AMPK and Downregulation of Oxidative Stress and Inflammation as Well as Dyslipidemia and Hypertension
por: Alshahrani, Mohammad Y., et al.
Publicado: (2023)

Thiazide–associated hyponatremia in the elderly: what the clinician needs to know
por: Liamis, George, et al.
Publicado: (2016)

Progressive, Qualitative, and Quantitative Alterations in HDL Lipidome from Healthy Subjects to Patients with Prediabetes and Type 2 Diabetes
por: Kostara, Christina E., et al.
Publicado: (2022)

8. Dyslipidemia at Chronic Renal Failure
por: Blaton, Victor
Publicado: (2009)

Association between Dyslipidemia and Chronic Rhinosinusitis in a Korean Population
por: Wee, Jee Hye, et al.
Publicado: (2020)

Do Uncontrolled Hypertension, Diabetes, Dyslipidemia, and Obesity Mediate the Relationship Between Health Literacy and Chronic Kidney Disease Complications?
por: Gurgel do Amaral, Matheus, et al.
Publicado: (2021)

The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
por: Thölking, Gerold, et al.
Publicado: (2021)

Malignancy-Associated Dyslipidemia
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2011)

Cumulative Effects of Hypertension, Dyslipidemia, and Chronic Kidney Disease on Carotid Atherosclerosis in Chinese Patients with Type 2 Diabetes Mellitus
por: Yuan, Chuang, et al.
Publicado: (2014)

An overview of lipid abnormalities in patients with inflammatory bowel disease
por: Agouridis, Aris P., et al.
Publicado: (2011)

Electrolyte and acid-base disorders in inflammatory bowel disease
por: Barkas, Fotis, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_casoa75i08em7a1prgq7dik2hf